Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous dexmedetomidine, dexamethasone, and interscalene block on duration of analgesia after arthroscopic shoulder surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Manitoba | Conditions: Pain, Postoperative, Shoulder Joint Disorder | Phase 4 | Status: COMPLETED